Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Damothara Thiruppathi

Pediatrics North Canton, OH Medical Doctor

NPI 1811002306 CMS profile 217588

4900 Frank Rd Nw, North Canton, OH 44720

Open in the dashboard

General payments

$5,612

399 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Damothara Thiruppathi of North Canton, OH is reported in the CMS Open Payments database as having received $5,612 across 399 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $590 30
2024 General $982 64
2023 General $997 63
2022 General $813 63
2021 General $1,032 80
2020 General $781 68
2019 General $417 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Damothara Thiruppathi
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Damothara Thiruppathi were reported at $590. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Damothara Thiruppathi Pediatrics median Middle half National median
2019 $417 $86 $31–$183 $163
2020 $781 $49 $22–$110 $114
2021 $1,032 $68 $27–$158 $132
2022 $813 $77 $30–$173 $149
2023 $997 $88 $33–$190 $160
2024 $982 $94 $34–$206 $164
2025 $590 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Corium, Inc. $1,385 103 payments
  2. Ironshore Pharmaceuticals Inc. $713 41 payments
  3. Tris Pharma Inc $606 52 payments
  4. Neos Therapeutics, LP $558 63 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $539 31 payments
  6. Pfizer Inc. $226 14 payments
  7. GlaxoSmithKline, LLC. $186 13 payments
  8. Merck Sharp & Dohme Corporation $184 13 payments
  9. Supernus Pharmaceuticals, Inc. $168 9 payments
  10. Adlon Therapeutics L.P. $157 11 payments
  11. Other $890 49 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,612 399 payments
Products named General payments · program years 2019–2025
  1. Azstarys $1,385 103 payments
  2. VYVANSE $511 29 payments
  3. JORNAY PM Central Nervous System Stimulant $498 27 payments
  4. COTEMPLA XR-ODT $430 49 payments
  5. Adzenys XR-ODT Adhd $231 26 payments
  6. Adzenys XR-ODT Adhd $198 26 payments
  7. Dyanavel XR $190 15 payments
  8. BEXSERO $186 13 payments
  9. GARDASIL 9 $171 12 payments
  10. JORNAY PM Central Nervous Stimulant ADHD $165 11 payments
  11. Other $2,808 184 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

399 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record